William Primos, MD
Sports Medicine · Dawsonville, GANPI 1528040458
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 41 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $232 and has fallen 76.8% since, to $54 in 2025. That places this record below the midpoint for sports medicine clinicians in GA, where the typical reported total is $903.
Across 41 payments — averaging $19.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ferring Pharmaceuticals Inc.$151
- Bioventus LLC$121
- Pacira Therapeutics, Inc.$66
- Amarin Pharma, Inc.$57
- Amgen$56
- AstraZeneca$55
- plus $282 from 11 others
What the payments were for
- Food & beverage$788100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 7 | $151 |
| Bioventus LLC | 3 | $121 |
| Pacira Therapeutics, Inc. | 4 | $66 |
| Amarin Pharma, Inc. | 3 | $57 |
| Amgen(2 entities) | 4 | $56 |
| AstraZeneca | 4 | $55 |
| Heron Therapeutics, Inc. | 2 | $43 |
| Smith+Nephew | 2 | $43 |
| Johnson & Johnson | 1 | $30 |
| Boehringer Ingelheim | 2 | $28 |
| Otsuka America Pharmaceutical, Inc. | 2 | $28 |
| Baxter Healthcare | 2 | $28 |
| Pfizer | 1 | $18 |
| Zyla Life Sciences, Inc. | 1 | $18 |
| Endo Pharmaceuticals Inc. | 1 | $17 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
| Cranial Technologies, Inc | 1 | $13 |
How this compares
$788 in reported general payments places this provider in the 45th percentile of 168 sports medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 25 | $77 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Dawsonville
- John XerogeanesAtlanta$4M
- Joseph BurnsAlpharetta$376K
- Sameh LabibBrookhaven$280K
- Spero KarasAtlanta$137K
- Xavier DuraldeAtlanta$77K
- Thomas MyersAtlanta$72K
- Robert O'ConnellCarrollton$69K
- Elan GolanSnellville$57K
- Taylor PolanderJesup$48K
- Anthony CantrellCanton$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.